MedPath

Evaluate the Safety, Functionality, and the Quality of Life of Patients Who Receive the Freedom Total Knee ® System

Not Applicable
Completed
Conditions
Knee Joint Pain
Interventions
Device: Freedom Total Knee
Device: Total Knee Replacement
Device: Freedom Total Knee System
Registration Number
NCT02056470
Lead Sponsor
Maxx Orthopedics Inc
Brief Summary

Assess the safety and functionality of the Freedom Knee® system through a multi-center clinical trial. Study endpoints include a comparison of Pre-Surgery versus Post-Surgery data for:

1. Range of Motion

2. Quality of Life measurements using Knee Society Scale (KSS)

3. Survivorship as defined by 'No Revision' of baseline implant

4. Quality of Life measurements using the WOMAC Score

Detailed Description

The clinical study will involve a series of evaluations performed by your surgeon. These examinations are consistent with the normal surgeon care as part of Total Knee Replacement surgery. The study objective is to assess the safety, functionality, and survivorship of the Freedom Knee System through a multi-center clinical trial. Study endpoints include a comparison of Pre-Surgery (baseline) versus Post-Surgery data for Range of Motion and Flexion, Quality of Life (KSS), and survivorship (defined by 'no revisions'). Additionally, the structural integrity will be evaluated based on the x-ray performed 36-months after knee replacement.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
211
Inclusion Criteria
  • Males and Females 40-80 years of age
  • Patients requiring knee prosthesis, and have been evaluated as appropriate candidates for aTKA by their orthopedic surgeon
  • Patients who understand the conditions of the study and are willing and able to comply with the post-operative scheduled clinical and the prescribed rehabilitation
Exclusion Criteria
  • Previous major knee replacement of the affected knee joint
  • Other significant disabling problems from the muscular-skeletal system than in the knees (i.e muscular dystrophy, polio, nueropathic joints)
  • Obese patients where obesity is severe enough to affect subject's ability to perform activities of daily living (body mass index, kg/m2: BMI > 35)
  • Patients who are found to be non-compliant by their physician
  • Patients with or having; malignancy - active malignancy, active or suspected infection, Paget's disease, renal osteodystrophy, immunologically suppressed, sickle cell anemia, and systemic lupus erythmatosus.
  • The patient has a neuromuscular or neurosensory deficit.
  • Female patients planning a pregnancy during the course of the study.
  • Patients, who are mentally incompetent or are unlikely to be compliant with the prescribed post-operative routine and follow-up evaluation schedule.
  • Varus or valgus deformity > 20 degrees

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Freedom Total Knee ReplacementFreedom Total Knee SystemFreedom Total Knee
Freedom Total Knee ReplacementTotal Knee ReplacementFreedom Total Knee
Freedom Total Knee ReplacementFreedom Total KneeFreedom Total Knee
Primary Outcome Measures
NameTimeMethod
Assess the safety and functionality of the Freedom Knee® system through a multi-center clinical trial3 years

The study is hoping to assess the safety of the implant by looking at the incident of revisions to the implant post surgery up to and including 3 years

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Maxx Ortho

🇺🇸

Norristown, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath